JP2019533665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533665A5 JP2019533665A5 JP2019518989A JP2019518989A JP2019533665A5 JP 2019533665 A5 JP2019533665 A5 JP 2019533665A5 JP 2019518989 A JP2019518989 A JP 2019518989A JP 2019518989 A JP2019518989 A JP 2019518989A JP 2019533665 A5 JP2019533665 A5 JP 2019533665A5
- Authority
- JP
- Japan
- Prior art keywords
- albumin
- bioactive polypeptide
- composition
- composition according
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662406367P | 2016-10-10 | 2016-10-10 | |
| US62/406,367 | 2016-10-10 | ||
| PCT/US2017/055902 WO2018071399A1 (en) | 2016-10-10 | 2017-10-10 | Nanoparticle formulations and methods of making and using thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019533665A JP2019533665A (ja) | 2019-11-21 |
| JP2019533665A5 true JP2019533665A5 (cg-RX-API-DMAC7.html) | 2020-11-19 |
Family
ID=61906258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019518989A Pending JP2019533665A (ja) | 2016-10-10 | 2017-10-10 | ナノ粒子製剤ならびにその作製方法および使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190247357A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3522854A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019533665A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190068570A (cg-RX-API-DMAC7.html) |
| CN (1) | CN109996527A (cg-RX-API-DMAC7.html) |
| AR (1) | AR109685A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017343553A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019007087A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3039195A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL265870A (cg-RX-API-DMAC7.html) |
| MA (1) | MA46474A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019003988A (cg-RX-API-DMAC7.html) |
| TW (1) | TW201825079A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018071399A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9675578B2 (en) | 2006-12-14 | 2017-06-13 | Abraxis Bioscience, Llc | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| PL2790675T3 (pl) | 2011-12-14 | 2019-12-31 | Abraxis Bioscience, Llc | Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| SMT202100642T1 (it) | 2015-06-29 | 2022-03-21 | Abraxis Bioscience Llc | Nanoparticelle comprendenti sirolimus e un'albumina per l'uso nel trattamento di tumori a cellule epitelioidi |
| AU2019239953B2 (en) | 2018-03-20 | 2025-01-02 | Abraxis Bioscience, Llc | Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin |
| IL292439B2 (en) | 2019-10-28 | 2026-05-01 | Abraxis Bioscience Llc | Pharmaceutical preparations of albumin and rapamycin |
| EP4054550A4 (en) * | 2019-11-05 | 2024-01-17 | Luminus Biosciences Inc. | NANOPARTICLES WITH PRODRUGS STABILIZED BY ALBUMIN FOR THE TREATMENT OF CANCER AND OTHER DISEASES |
| US20230001009A1 (en) * | 2019-12-04 | 2023-01-05 | The Trustees Of The University Of Pennsylvania | Nanoparticle compositions and methods of use |
| KR102526793B1 (ko) * | 2021-11-03 | 2023-04-28 | 주식회사 에스엔바이오사이언스 | 입도분포 유지 안정성이 개선된 알부민 결합 탁산 나노입자 제조방법 |
| CN116889618B (zh) * | 2023-09-08 | 2023-12-01 | 四川大学华西医院 | 一种治疗糖尿病皮肤创面的药物及其制备方法 |
| WO2026063717A1 (ko) * | 2024-09-19 | 2026-03-26 | 경북대학교 산학협력단 | 의료용 접착제 조성물 및 그 제조방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62228025A (ja) * | 1985-12-27 | 1987-10-06 | Teijin Ltd | 抗体複合体の製造方法 |
| WO1999000113A1 (en) * | 1997-06-27 | 1999-01-07 | Vivorx Pharmaceuticals, Inc. | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| ATE252894T1 (de) * | 1995-01-05 | 2003-11-15 | Univ Michigan | Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung |
| CN1169827C (zh) * | 2001-08-07 | 2004-10-06 | 沈阳三生制药股份有限公司 | 一种增强多肽在体内稳定性药物的生产方法及其应用 |
| DE102004011776A1 (de) * | 2004-03-09 | 2005-11-03 | Lts Lohmann Therapie-Systeme Ag | Trägersystem in Form von Nanopartikeln auf Proteinbasis zur zellspezifischen Anreicherung von pharmazeutisch aktiven Wirkstoffen |
| JP2013510804A (ja) * | 2009-11-13 | 2013-03-28 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 化学療法剤を装荷したナノ粒子に結合した抗インテグリン抗体 |
| US20120225129A1 (en) * | 2010-08-20 | 2012-09-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| EP2655413B1 (en) * | 2010-12-23 | 2019-01-16 | F.Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
| HUE048876T2 (hu) * | 2011-05-09 | 2020-08-28 | Mayo Found Medical Education & Res | Rákos megbetegedések kezelése |
| US10413606B2 (en) * | 2012-10-01 | 2019-09-17 | Mayo Foundation For Medical Education And Research | Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies |
| EP3154586B1 (en) * | 2014-06-13 | 2020-05-27 | Mayo Foundation for Medical Education and Research | Treating lymphomas |
| US10213513B2 (en) * | 2014-06-16 | 2019-02-26 | Mayo Foundation For Medical Education And Research | Treating myelomas |
| CN107073132B (zh) * | 2014-10-06 | 2021-08-27 | 梅约医学教育与研究基金会 | 载体-抗体组合物及其制备和使用方法 |
-
2017
- 2017-10-10 WO PCT/US2017/055902 patent/WO2018071399A1/en not_active Ceased
- 2017-10-10 MX MX2019003988A patent/MX2019003988A/es unknown
- 2017-10-10 BR BR112019007087A patent/BR112019007087A2/pt not_active Application Discontinuation
- 2017-10-10 JP JP2019518989A patent/JP2019533665A/ja active Pending
- 2017-10-10 AR ARP170102820A patent/AR109685A1/es unknown
- 2017-10-10 EP EP17860752.9A patent/EP3522854A4/en active Pending
- 2017-10-10 CN CN201780072461.1A patent/CN109996527A/zh active Pending
- 2017-10-10 US US16/340,676 patent/US20190247357A1/en not_active Abandoned
- 2017-10-10 KR KR1020197013054A patent/KR20190068570A/ko not_active Ceased
- 2017-10-10 AU AU2017343553A patent/AU2017343553A1/en not_active Abandoned
- 2017-10-10 CA CA3039195A patent/CA3039195A1/en not_active Abandoned
- 2017-10-10 MA MA046474A patent/MA46474A/fr unknown
- 2017-10-11 TW TW106134822A patent/TW201825079A/zh unknown
-
2019
- 2019-04-07 IL IL265870A patent/IL265870A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10961317B2 (en) | CD20 scFv-ELPs methods and therapeutics | |
| RU2021128415A (ru) | Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения | |
| Jiang et al. | Recent advances of halloysite nanotubes in biomedical applications | |
| Tan et al. | Functionalization of graphene oxide generates a unique interface for selective serum protein interactions | |
| Sarparanta et al. | Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution | |
| CN116059171B (zh) | 用于将生理活性成分递送至血管的组合物 | |
| RU2680404C2 (ru) | Способ очистки cys-связанных конъюгатов антитело-лекарственное средство | |
| Hashemi-Moghaddam et al. | Evaluation of molecularly imprinted polymer based on HER2 epitope for targeted drug delivery in ovarian cancer mouse model | |
| JP2021505540A5 (cg-RX-API-DMAC7.html) | ||
| CN112807299B (zh) | 包含多西他赛和人血清白蛋白的固体组合物及其制备方法和应用 | |
| CN109996527A (zh) | 纳米颗粒制剂及其制备和使用方法 | |
| RU2008134011A (ru) | Усовершенствованное получение полимеров с молекулярными отпечатками | |
| JP2011519932A5 (cg-RX-API-DMAC7.html) | ||
| Abdouss et al. | Development and characterization of molecularly imprinted polymers for controlled release of citalopram | |
| Adeli et al. | Controlled curcumin delivery via carboxymethyl starch‐modified gamma alumina nanoparticles in a polyethylene glycol‐based hydrogel | |
| Paşcalău et al. | Bovine serum albumin gel/polyelectrolyte complex of hyaluronic acid and chitosan based microcarriers for Sorafenib targeted delivery | |
| RU2017129729A (ru) | Конъюгаты антитело-уреаза для терапевтических целей | |
| Saha et al. | Preclinical Development of a Genetically Engineered Albumin‐Binding Nanoparticle of Paclitaxel | |
| CN104814934A (zh) | 一种曲妥株单抗修饰的载紫杉醇的靶向纳米粒传递系统 | |
| CA2642324C (en) | Stable pharmaceutical composition of taxanes | |
| US20150209335A1 (en) | Methods and small molecule therapeutics comprising fused elps | |
| JP2022526979A5 (cg-RX-API-DMAC7.html) | ||
| US12427109B2 (en) | Natural origin stabilizer for oil in water emulsions | |
| JP2011519893A5 (cg-RX-API-DMAC7.html) | ||
| Csikós et al. | Crosslinked poly-γ-glutamic acid based nanosystem for drug delivery |